Exicure, Inc. Share Price & Technical Analysis
XCUR · $2.67 (-4.98%)
Healthcare / Biotechnology
$2.67
-4.98%
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood Cit…
Price chart
Seasonality
May has 0 positive and 5 negative years (last 5 years shown)
-12% return in May, -13% avg return in past 3 year May month.
-46% return in 2026, 238% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -24% | -12% | 19% | -17% | -12% | – | – | – | – | – | – | – | -46% |
| 25 | -19% | -16% | 34% | -26% | -3% | -30% | 15% | -21% | -25% | 13% | -9% | 23% | -66% |
| 24 | -7% | 30% | -17% | -13% | -15% | -30% | 29% | -9% | 84% | -17% | 852% | -54% | 832% |
| 23 | 25% | -19% | -24% | 11% | -20% | 57% | -25% | -13% | -22% | -16% | -26% | 21% | -51% |
| 22 | -10% | 2% | -2% | -28% | -8% | -45% | -23% | 15% | -12% | -8% | -30% | 21% | -127% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$20.65M
P/E ratio
—
52W high
$10.80
52W low
$2.63
Volume
6,283
Beta
3.62
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Exicure, Inc. share price today?
- Exicure, Inc. (XCUR) last traded around $2.67 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does XCUR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for XCUR. Download the app for real-time alerts.
- How can I analyze Exicure, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.